Methylome-wide Association Study of Patients with Recent-onset Psychosis
10.9758/cpn.2022.20.3.462
- Author:
Yan-Hong PIAO
1
;
Yin CUI
;
Fatima Zahra RAMI
;
Ling LI
;
Maryam KARAMIKHEIRABAD
;
Shi Hyun KANG
;
Sung-Wan KIM
;
Jung Jin KIM
;
Bong Ju LEE
;
Young-Chul CHUNG
Author Information
1. Department of Psychiatry, Jeonbuk National University Medical School, Jeonju, Korea
- Publication Type:Original Article
- From:Clinical Psychopharmacology and Neuroscience
2022;20(3):462-473
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objective:Dysregulation of gene expression through epigenetic mechanisms may have a vital role in the pathogenesis of schizophrenia (SZ). In this study, we investigated the association of altered methylation patterns with SZ symptoms and early trauma in patients and healthy controls.
Methods:The present study was conducted to identify methylation changes in CpG sites in peripheral blood associated with recent-onset (RO) psychosis using methylome-wide analysis. Lifestyle factors, such as smoking, alcohol, exercise, and diet, were controlled.
Results:We identified 2,912 differentially methylated CpG sites in patients with RO psychosis compared to controls. Most of the genes associated with the top 20 differentially methylated sites had not been reported in previous methylation studies and were involved in apoptosis, autophagy, axonal growth, neuroinflammation, protein folding, etc. The top 15 significantly enriched Kyoto Encyclopedia of Genes and Genomes pathways included the oxytocin signaling pathway, long-term depression pathway, axon guidance, endometrial cancer, long-term potentiation, mitogen-activated protein kinase signaling pathway, and glutamatergic pathway, among others. In the patient group, significant associations of novel methylated genes with early trauma and psychopathology were observed.
Conclusion:Our results suggest an association of differential DNA methylation with the pathophysiology of psychosis and early trauma. Blood DNA methylation signatures show promise as biomarkers of future psychosis.
